The current valuation score of Entera Bio Ltd is 6.65, ranking 304 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.45, which is -75.24% below the recent high of -1.60 and -89.79% above the recent low of -12.25.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.